Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports
    Finance

    Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports

    Published by Global Banking & Finance Review®

    Posted on January 20, 2026

    2 min read

    Last updated: January 20, 2026

    Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:managementcorporate strategyMergers and Acquisitions

    Quick Summary

    Qiagen is exploring strategic options, including a sale, amid renewed takeover interest, with shares rising 14% as the market reacts.

    Table of Contents

    • Qiagen's Strategic Review and Market Response
    • CEO Departure and Its Impact
    • Market Reaction to Takeover Talks

    Qiagen Considers Strategic Options Amid New Takeover Interest

    Qiagen's Strategic Review and Market Response

    Jan 20 (Reuters) - Qiagen is weighing strategic options, including a potential sale of the diagnostics firm amid fresh takeover interest, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.

    U.S.-listed shares of the company were up 14% in afternoon trade.

    The Netherlands-based company is working with advisers as its supervisory board fields preliminary interest from potential suitors, the report said, adding Qiagen has held talks with several possible buyers in recent weeks, including some U.S. strategics.

    CEO Departure and Its Impact

    In recent years, the company has attracted multiple instances of takeover, though the discussions never led to a deal. Deliberations are still at an early stage and there is no certainty the latest talks will result in a sale, the Bloomberg report said.

    Market Reaction to Takeover Talks

    Qiagen said in November its Chief Executive Officer Thierry Bernard will leave as soon as a successor is found. His planned departure removes one of the biggest perceived roadblocks to a potential deal, according to some sources cited in the report.

    The company did not immediately respond to a Reuters request for comment.

    (Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)

    Key Takeaways

    • •Qiagen is considering a potential sale amid new takeover interest.
    • •The company is working with advisers and has received preliminary interest.
    • •CEO Thierry Bernard's departure may facilitate a potential deal.
    • •U.S.-listed shares of Qiagen rose 14% following the news.
    • •There is no certainty that current talks will result in a sale.

    Frequently Asked Questions about Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports

    1What is a strategic review?

    A strategic review is an assessment process where a company evaluates its current strategy, operations, and market position to identify opportunities for improvement or change.

    2What is a takeover?

    A takeover occurs when one company acquires control over another company, typically by purchasing a majority of its shares.

    3What is a CEO departure?

    A CEO departure refers to the situation when a company's Chief Executive Officer resigns or is removed from their position, which can impact the company's strategic direction.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostBottega Veneta CEO Bartolomeo Rongone to step down, Kering says
    Next Finance PostStarmer rival Burnham says UK bond investors safe under his economic vision